ArticleFrontiers in oncology2026

Can neoadjuvant endocrine therapy de-escalate surgery in luminal breast cancer? A four-year retrospective study from a single referral center.

Aleksander Skulimowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.